Kathy Samii

Crew Gold Corp. develops and operates gold resource projects. The company was founded in 1980 and is headquartered in London, the United Kingdom.

Citigroup Global Markets Europe Ltd. provides investment banking services. The company was founded on March 5, 1981 and is headquartered in London, the United Kingdom.

Adelphi Capital LLP is the alternative investment management subsidiary of Adelphi Capital Management Ltd. in Great Britain. The firm was founded in 1997 by Roderick Jack and Marcel Jongen. Headquartered in London, Adelphi Capital provides investment advice on a discretionary basis to onshore and offshore private investment funds that are offered to high net-worth, financially sophisticated, individual and institutional investors.

MMC Ventures Ltd.(MMC Ventures) is a venture capital firm founded in 2000 by Bruce Ferguson MacFarlane and Alan William Morgan. The firm is headquartered in London.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

Arvia Technology Ltd. provides water treatment and conservation technology and solutions. It products the Arvia Organics Destruction Cell (ODC) is a water and wastewater treatment system designed to reduce recalcitrant Chemical Oxygen Demand (COD), remove colour and destroy micro-pollutants. It serves to the chemicals, food, beverage, nuclear, pharmaceuticals and utilities. The company was founded by Nigel Willis Brown and Edward Roberts in 2007 and is headquartered in Warrington, the United Kingdom.

AMS Sensors UK Ltd. provides gas sensor solutions for consumer applications. The company was founded on June 20, 2007 and is headquartered in Cambridge, the United Kingdom.

Parkwalk Advisors Ltd. provides investment advisory services. The company was founded by Alastair Kilgour in 2009 and is headquartered in London, the United Kingdom.

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.

Part of Avacta Group Plc, Aptuscan Ltd. provides biotechnology research in the development of various products. The company is based in Leeds, UK. Aptuscan was acquired by Avacta Group Plc on January 10, 2012 for $2.50 million.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom.

Spectral Edge Ltd. develops image fusion technology. Its products include PHUSION for photography, multispectral vision and video personalization. The company was founded by Robert Edward Meredith Swann, David Connah, Graham D. Finlayson, Mark S. Drew and Joita Dey in February 2011 and is headquartered in Cambridge, the United Kingdom.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Fuel 3D Technologies Ltd. develops and manufactures 3D scanning systems and solutions. The company was founded by Ronald Daniel and James A. Peterson in 2014 and is headquartered in Oxford, the United Kingdom.

Silicon Microgravity Ltd. develops sensor devices for the oil and gas sector. Its sensing technology enables the recording of gravity data at high sensitivities and seismic data at ultra-low frequencies. The firm offers microelectromechanical system sensors to transform measuring densities deep in the reservoir from the borehole. The company was founded by Paul Vickery, Ashwin Seshia and Kevin Dodds in September 2013 and is headquartered in Cambridge, the United Kingdom.

Cambridge Touch Technologies Ltd. engages in the development of software technology innovation services. Its product features includes flexible and foldable. low power, pressure sensitive, multi-touch, scalable to any size, easy to manufacture, solid state and robust, low cost, and wide temperature range. The company was founded by Corbin Church and Arokia Nathan in 2011 and is headquartered in Cambridge, the United Kingdom.

Inflowmatix Ltd. designs and implements electronic systems that provide water flow and system health analytics to water utilities worldwide. It offers leakage and burst prevention solutions, pressure management and starter kit. The company was founded by Ivan Stoianov, Kelsey Lynn Skinner and David Gareth Parker on May 1, 2015 and is headquartered in Hampshire, the United Kingdom.

Oxford Quantum Circuits Ltd. engages in quantum research. Its research includes research stories, major themes, and impacts. The company was founded by Peter James Leek on June 5, 2017 and is headquartered in Oxford, the United Kingdom.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.

Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom.